Research Study

Moderna COVID Flu Combination Vaccine Study

This is a real-world study evaluating the effectiveness of mRNA-1083 (Moderna’s influenza and COVID-19 combination vaccine) in preventing seasonal Influenza and COVID-19 hospitalizations among adults 50 years and older. The Moderna protocol number is mRNA-1083-P904.

Principal Investigator:

Hung Fu Tseng, PhD, MPH

Funding Source:

ModernaTX, Inc.

Funding Years:

2024 - 2025